A urine extracellular vesicle lncRNA classifier for high-grade prostate cancer and increased risk of progression: A multi-center study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A urine extracellular vesicle lncRNA classifier for high-grade prostate cancer and increased risk of progression: A multi-center study

Published:2023-10 Issue:10 Volume:4 Page:101240
ISSN:2666-3791
Container-title:Cell Reports Medicine
language:en
Short-container-title:Cell Reports Medicine

Author:

Tao Wen,Wang Bang-Yu,Luo Liang,Li Qing,Meng Zhan-Ao,Xia Tao-Lin,Deng Wei-Ming,Yang Ming,Zhou Jing,Zhang Xin,Gao Xin,Li Liao-Yuan,He Ya-Di

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference50 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA A Cancer J. Clin.,2018

2. A randomized trial of risk-adapted screening for prostate cancer in young men-Results of the first screening round of the PROBASE trial;Arsov;Int. J. Cancer,2022

3. Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10 ng/ml: systematic review and meta-analysis;Roddam;Eur. Urol.,2005

4. Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study;Grönberg;Lancet Oncol.,2015

5. Active surveillance for prostate cancer: a systematic review of clinicopathologic variables and biomarkers for risk stratification;Loeb;Eur. Urol.,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcript Markers from Urinary Extracellular Vesicles for Predicting Risk Reclassification of Prostate Cancer Patients on Active Surveillance;Cancers;2024-07-04

2. Applications of Urinary Extracellular Vesicles in the Diagnosis and Active Surveillance of Prostate Cancer;Cancers;2024-04-28

3. Early Detection, Precision Treatment, Recurrence Monitoring: Liquid Biopsy Transforms Colorectal Cancer Therapy;Current Cancer Drug Targets;2024-04-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3